: Canopy Growth’s stock falls back from recent gains as cannabis stocks cool off

The optimism around a potential rescheduling of cannabis fades as 14 Republican members of Congress say pot should remain a Schedule I drug under federal law.

Previous post : Child poverty in the U.S. more than doubled as pandemic help expired
Next post Asset manager Franklin Templeton applies to launch a spot Bitcoin ETF